razoxane has been researched along with Leukemia in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (50.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eastmond, DA; Roy, SK | 1 |
| Giraldi, T; Sava, G | 1 |
| Allan, WP; Fattman, CL; Hasinoff, BB; Yalowich, JC | 1 |
| Abram, ME; Allan, WP; Barnabé, N; Hasinoff, BB; Khélifa, T; Yalowich, JC | 1 |
| Budman, DR; Calabro, A; Kreis, W | 1 |
| Balwierz, W; Kowalczyk, JR; Styczynski, J; Wysocki, M | 1 |
| Comelli, A; Massimo, L | 1 |
| Das, S; Freedman, LS; Garrett, MJ; Smith, JD | 1 |
| Bakowski, MT; Lister, TA; Malpas, JS; McElwain, TJ; Powles, RL; Prentice, HG | 1 |
| Krepler, P; Pawlowsky, J | 1 |
| Bakowski, MT | 1 |
| Forbes, JF | 1 |
| Kamen, B; Krischer, JP; Vats, T | 1 |
| Hammershaimb, LD; Hurson, SB; Marsoni, S; Simon, RM; Ungerleider, RS | 1 |
2 review(s) available for razoxane and Leukemia
| Article | Year |
|---|---|
Selective antimetastatic drugs (review).
Topics: Animals; Antineoplastic Agents; Hemostasis; Humans; Leukemia; Leukemia, Experimental; Mice; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Protease Inhibitors; Rats; Razoxane | 1981 |
Long-term effects of adjuvant chemotherapy in breast cancer.
Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Female; Heart; Heart Diseases; Hodgkin Disease; Humans; Leukemia; Lymphatic Metastasis; Menopause; Menstruation; Monitoring, Physiologic; Neoplasms, Second Primary; Ovary; Razoxane | 1992 |
3 trial(s) available for razoxane and Leukemia
| Article | Year |
|---|---|
Limited activity of ICRF-159 in advanced acute leukemia.
Topics: Clinical Trials as Topic; Cytarabine; Drug Therapy, Combination; Humans; Leukemia; Leukemia, Lymphoid; Piperazines; Razoxane | 1979 |
Clinical trials with bis-dioxopiperazine propane (ICRF 159; NSC 129, 943) in acute leukaemias.
Topics: Acute Disease; Antineoplastic Agents; Child; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Leukemia; Piperazines; Razoxane | 1975 |
Phase II trial of ICRF-187 in children with solid tumors and acute leukemia.
Topics: Acute Disease; Adolescent; Child; Drug Evaluation; Humans; Leukemia; Neoplasms; Razoxane | 1991 |
9 other study(ies) available for razoxane and Leukemia
| Article | Year |
|---|---|
Bimolane induces multiple types of chromosomal aberrations in human lymphocytes in vitro.
Topics: Antineoplastic Agents; Cells, Cultured; Chromosome Aberrations; Humans; In Situ Hybridization, Fluorescence; Leukemia; Lymphocytes; Male; Micronuclei, Chromosome-Defective; Mutagens; Neoplasms, Second Primary; Nondisjunction, Genetic; Polyploidy; Razoxane | 2011 |
Collateral sensitivity to the bisdioxopiperazine dexrazoxane (ICRF-187) in etoposide (VP-16)-resistant human leukemia K562 cells.
Topics: Alkenes; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Humans; Leukemia; Polyenes; Pyrones; Razoxane; Thiobarbiturates | 1996 |
The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces differentiation and apoptosis in human leukemia K562 cells.
Topics: Antineoplastic Agents; Apoptosis; Catalysis; Cell Differentiation; Cell Division; Cell Size; DNA Topoisomerases, Type II; Enzyme Inhibitors; HL-60 Cells; Humans; K562 Cells; Leukemia; Razoxane; Topoisomerase II Inhibitors | 2001 |
In vitro effects of dexrazoxane (Zinecard) and classical acute leukemia therapy: time to consider expanded clinical trials?
Topics: Acute Disease; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cell Death; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Humans; Inhibitory Concentration 50; Leukemia; Mitoxantrone; Razoxane; Tumor Cells, Cultured | 2001 |
Dexrazoxane has no impact on sensitivity of childhood leukemic blasts to daunorubicin.
Topics: Adolescent; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Survival; Child; Child, Preschool; Daunorubicin; Drug Interactions; Drug Resistance, Neoplasm; Flow Cytometry; HL-60 Cells; Humans; Infant; K562 Cells; Leukemia; Razoxane; Tumor Cells, Cultured | 2002 |
[New drugs for the therapy of acute leukemia].
Topics: Acute Disease; Antineoplastic Agents; Azacitidine; Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Guanazole; Humans; Leukemia; Lomustine; Peptichemio; Podophyllotoxin; Razoxane; Zinostatin | 1975 |
Long term experience with combination chemotherapy in advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Bleomycin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Male; Mechlorethamine; Middle Aged; Mutagens; Neoplasms, Multiple Primary; Oxymetholone; Prednisone; Pregnancy; Procarbazine; Razoxane; Teratogens; Vinblastine; Vincristine | 1977 |
ICRF 159, (+/-) 1,2-di(3,5-dioxopiperazin-1-yl) propane NSC-129,943; razoxane.
Topics: Animals; Antineoplastic Agents; Cricetinae; Dogs; Drug Synergism; Haplorhini; Humans; Immunosuppressive Agents; Leukemia; Neoplasm Metastasis; Neoplasms; Piperazines; Rabbits; Radiation-Sensitizing Agents; Rats; Razoxane; Teratogens | 1976 |
Tolerance to antineoplastic agents in children and adults.
Topics: Adult; Ancitabine; Antineoplastic Agents; Child; Dose-Response Relationship, Drug; Drug Evaluation; Drug Tolerance; Humans; Hypotension; Leukemia; Lymphoma; Neoplasms; Posture; Razoxane; Retrospective Studies | 1985 |